Robert Legaspi

Leukemia in Remission for First Patient to Undergo CAR T-Cell Immunotherapy in San Diego

Robert Legaspi was 9 years old when he was first diagnosed with acute lymphoblastic leukemia. This year, at age 27, his leukemia returned for the fourth time. This time was different, though — on May 20, 2016, Legaspi became the first patient in San Diego to receive a new type of immunotherapy, known as CAR T-cell therapy, as part of a Phase I/II clinical trial at Moores Cancer Center at UC San Diego Health. His leukemia is now in remission again, more quickly and after a much better therapeutic experience.

wearable sensor

Flexible Wearable Electronic Skin Patch Offers New Way to Monitor Alcohol Levels

Engineers at UC San Diego have developed a flexible wearable sensor that can accurately measure a person’s blood alcohol level from sweat and transmit the data wirelessly to a laptop, smartphone or other mobile device. The device can be worn on the skin and could be used by doctors and police officers for continuous, non-invasive and real-time monitoring of blood alcohol content.

Sustainable science gateways

NSF Awards $15 Million to Create Science Gateways Community Institute

The National Science Foundation (NSF) has awarded a five-year $15 million grant to a collaborative team led by the San Diego Supercomputer Center (SDSC) at UC San Diego to establish a Science Gateways Community Institute to accelerate the development and application of highly functional, sustainable science gateways that address the needs of researchers across the full spectrum of NSF directorates.

UCSD Mobile